The relevance of long-acting injectables in the treatment of schizophrenia

Lancet Psychiatry. 2023 Mar;10(3):159-160. doi: 10.1016/S2215-0366(23)00033-0. Epub 2023 Jan 27.

Authors

Martina Hahn¹, Sibylle Christine Roll²

Affiliations

¹ Department of Psychiatry, Psychosomatics, And Psychotherapy, University Hospital-Goethe University, 60528 Frankfurt, Germany; Department of Mental Health, Varisano Klinikum Frankfurt Hoechst, Frankfurt, Germany. Electronic address: martina.hahn@kgu.de.
² Department of Mental Health, Varisano Klinikum Frankfurt Hoechst, Frankfurt, Germany.

PMID: 36716760
DOI: 10.1016/S2215-0366(23)00033-0

No abstract available

Publication types

Comment

MeSH terms

Antipsychotic Agents* / therapeutic use
Humans
Injections
Schizophrenia* / drug therapy

Substances

Antipsychotic Agents